We analyzed data from HIV-infected individuals who were clinically-eligible for ART between 2001 and 2009 ( i.e. , a first reported CD4 + < 350 cells/uL or AIDS-defining illness ) from 14 U.S. cohorts of the North American AIDS Cohort Collaboration on Research and Design ( NA-ACCORD ) .